False claims of blood pressure-independent protection by blockade of the renin angiotensin aldosterone system?

被引:40
作者
Kurtz, TW [1 ]
机构
[1] Univ Calif San Francisco, Med Ctr, Dept Lab Med, San Francisco, CA 94143 USA
关键词
D O I
10.1161/01.HYP.0000049882.23078.EB
中图分类号
R6 [外科学];
学科分类号
1002 [临床医学]; 100210 [外科学];
摘要
引用
收藏
页码:193 / 196
页数:4
相关论文
共 35 条
[1]
*ALLHAT OFF COORD, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981
[2]
Telemetry for cardiovascular monitoring in a pharmacological study - New approaches to data analysis [J].
Anderson, NH ;
Devlin, AM ;
Graham, D ;
Morton, JJ ;
Hamilton, CA ;
Reid, JL ;
Schork, NJ ;
Dominiczak, AF .
HYPERTENSION, 1999, 33 (01) :248-255
[3]
[Anonymous], KIDNEY
[4]
[Anonymous], 1997, ARCH INTERN MED, V157, P2413, DOI DOI 10.1001/ARCHINTE.1997.00440420033005
[5]
Preserving renal function in adults with hypertension and diabetes: A consensus approach [J].
Bakris, GL ;
Williams, M ;
Dworkin, L ;
Elliott, WJ ;
Epstein, M ;
Toto, R ;
Tuttle, K ;
Douglas, J ;
Hsueh, W ;
Sowers, J .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 36 (03) :646-661
[6]
CONTINUOUS TELEMETRIC BLOOD-PRESSURE MONITORING AND GLOMERULAR INJURY IN THE RAT REMNANT KIDNEY MODEL [J].
BIDANI, AK ;
GRIFFIN, KA ;
PICKEN, M ;
LANSKY, DM .
AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 265 (03) :F391-F398
[7]
Lack of evidence of blood pressure-independent protection by renin-angiotensin system blockade after renal ablation [J].
Bidani, AK ;
Griffin, KA ;
Bakris, G ;
Picken, MM .
KIDNEY INTERNATIONAL, 2000, 57 (04) :1651-1661
[8]
Long-term renal consequences of hypertension for normal and diseased kidneys [J].
Bidani, AK ;
Griffin, KA .
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2002, 11 (01) :73-80
[9]
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy [J].
Brenner, BM ;
Cooper, ME ;
de Zeeuw, D ;
Keane, WF ;
Mitch, WE ;
Parving, HH ;
Remuzzi, G ;
Snapinn, SM ;
Zhang, ZX ;
Shahinfar, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :861-869
[10]
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol [J].
Dahlöf, B ;
Devereux, RB ;
Kjeldsen, SE ;
Julius, S ;
Beevers, G ;
de Faire, U ;
Fyhrquist, F ;
Ibsen, H ;
Kristiansson, K ;
Lederballe-Pedersen, O ;
Lindholm, LH ;
Nieminen, MS ;
Omvik, P ;
Oparil, S ;
Wedel, H .
LANCET, 2002, 359 (9311) :995-1003